NPDR - NON PROLIFERATIVE DIABETIC RETINOPATHY
Clinical trials for NPDR - NON PROLIFERATIVE DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new NPDR - NON PROLIFERATIVE DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for NPDR - NON PROLIFERATIVE DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a daily pill replace eye injections for diabetic retinopathy?
Disease control CompletedThis study tested an oral medication called APX3330 in 103 adults with diabetic retinopathy, a leading cause of vision loss. The pill aims to reduce inflammation and low-oxygen damage in the eye. Researchers measured whether it could improve the severity of the disease over 24 we…
Matched conditions: NPDR - NON PROLIFERATIVE DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Ocuphire Pharma, Inc. • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Eye scans could predict vision loss in diabetes patients
Knowledge-focused CompletedThis study looked at 202 adults with type 2 diabetes and early-stage diabetic eye disease (non-proliferative diabetic retinopathy). Researchers used non-invasive eye scans to find markers that could predict if the disease would get worse or lead to sight-threatening problems. The…
Matched conditions: NPDR - NON PROLIFERATIVE DIABETIC RETINOPATHY
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:05 UTC